# IGC Pharma, Inc.: Form 10-Q for the period ended Sep 30, 2011

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: 10-Q
- Filed: 2011-11-18
- Accepted by EDGAR: Nov 18, 2011, 17:19 ET
- Period: 2011-09-30
- Accession: 0001185185-11-002076
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518511002076/indiaglobal10q093011.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518511002076/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2011-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2011-07-01 to 2011-09-30 | $912.1k | us-gaap:Revenues |
| Revenue | 6 months, 2011-04-01 to 2011-09-30 | $2.0m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2011-07-01 to 2011-09-30 | $903.5k | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months, 2011-04-01 to 2011-09-30 | $1.9m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months, 2011-07-01 to 2011-09-30 | $652.4k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2011-04-01 to 2011-09-30 | $1.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2011-07-01 to 2011-09-30 | −$719.4k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2011-04-01 to 2011-09-30 | −$1.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2011-07-01 to 2011-09-30 | $149.0k | us-gaap:InterestExpense |
| Interest expense | 6 months, 2011-04-01 to 2011-09-30 | $449.7k | us-gaap:InterestExpense |
| Net income | 3 months, 2011-07-01 to 2011-09-30 | −$789.3k | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2011-04-01 to 2011-09-30 | −$1.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2011-07-01 to 2011-09-30 | −$0.04 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2011-04-01 to 2011-09-30 | −$0.08 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2011-07-01 to 2011-09-30 | −$0.04 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2011-04-01 to 2011-09-30 | −$0.08 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2011-07-01 to 2011-09-30 | 20,960,433 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2011-04-01 to 2011-09-30 | 20,699,660 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2011-04-01 to 2011-09-30 | −$813.8k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2011-09-30 | $766.8k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2011-09-30 | $5.8m | us-gaap:AssetsCurrent |
| Total assets | at 2011-09-30 | $16.1m | us-gaap:Assets |
| Current liabilities | at 2011-09-30 | $6.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2011-09-30 | $6.7m | us-gaap:Liabilities |
| Short-term borrowings | at 2011-09-30 | $818.5k | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2011-09-30 | $5.7m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518511002076/indiaglobal10q093011.htm

Filed Nov 18, 2011.
Source: SEC EDGAR, the filing index for accession 0001185185-11-002076. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.
